▶ 調査レポート

淋菌感染症治療のアジア市場：市場規模・シェア・価格・動向・予測
• 英文タイトル：Asia Pacific Neisseria Gonorrhoeae Infections Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Prof Researchが調査・発行した産業分析レポートです。淋菌感染症治療のアジア市場：市場規模・シェア・価格・動向・予測 / Asia Pacific Neisseria Gonorrhoeae Infections Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast / D0FB0635151資料のイメージです。• レポートコード：D0FB0635151
• 出版社/出版日：Prof Research / 2019年12月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、149ページ
• 納品方法：Eメール（受注後2-3営業日）
• 産業分類：製薬・医療
• 販売価格（消費税別）
  Single User￥420,000 (USD3,000)▷ お問い合わせ
  Site License￥532,000 (USD3,800)▷ お問い合わせ
  Global Site License￥700,000 (USD5,000)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
淋菌感染症治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は淋菌感染症治療の市場概要、産業チェーン、市場動向、市場規模予測、需要先情報、関連企業情報などを収録しており、アジアにおける淋菌感染症治療市場の詳細な情報を探している方にとって有用な参考資料です。日本、中国、インド、韓国、インドネシア、マレーシア、フィリピン、タイ、ベトナム、シンガポール、オーストラリアなどを地域を対象にしています。
・市場概要
・産業チェーン分析（ファイブフォース分析、コスト構造分析）
・市場動向
・淋菌感染症治療のアジア市場規模推移2014-2019
・淋菌感染症治療のアジア市場規模予測2019-2024
・淋菌感染症治療のサプライヤー分析
・顧客（需要先）分析
・主要企業分析（Allergan Plc、BioDiem Ltd、Biolytics Pharma、Debiopharm International SA、F. Hoffmann-La Roche Ltd.、GlaxoSmithKline Plc、Merck& Co.、Inc.、Paratek Pharmaceuticals、Inc.、Recce Pty Ltd、Redx Pharma Pl）
・結論

Abstract:

The Asia Pacific Neisseria Gonorrhoeae Infections Treatment market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD by the end of 2024 with a CAGR of XX% from 2019 to 2024.

This report is an essential reference for who looks for detailed information on Asia Pacific Neisseria Gonorrhoeae Infections Treatment market. The report covers data on Asia Pacific markets including historical and future trends for supply, market size, prices, trading, competition and value chain as well as Asia Pacific major vendors¡¯ information. In addition to the data part, the report also provides overview of Neisseria Gonorrhoeae Infections Treatment market, including classification, application, manufacturing technology, industry chain analysis and latest market dynamics. Finally, a customization report in order to meet user’s requirements is also available.

Key Points of this Report:

* The depth industry chain include analysis value chain analysis, porter five forces model analysis and cost structure analysis
* The report covers Asia Pacific and country-wise market of Neisseria Gonorrhoeae Infections Treatment
* It describes present situation, historical background and future forecast
* Comprehensive data showing Neisseria Gonorrhoeae Infections Treatment capacities, production, consumption, trade statistics, and prices in the recent years are provided
* The report indicates a wealth of information on Neisseria Gonorrhoeae Infections Treatment manufacturers
* Neisseria Gonorrhoeae Infections Treatment market forecast for next five years, including market volumes and prices is also provided
* Raw Material Supply and Downstream Consumer Information is also included
* Any other user’s requirements which is feasible for us

The largest vendors of Asia Pacific Neisseria Gonorrhoeae Infections Treatment market: (At least 10 companies included)
* Allergan Plc
* BioDiem Ltd
* Biolytics Pharma
* Debiopharm International SA
* F. Hoffmann-La Roche Ltd.
* GlaxoSmithKline Plc
For complete list, please ask for sample pages.

The Neisseria Gonorrhoeae Infections Treatment market in Asia Pacific is segmented by countries:
* China
* India
* Japan
* South Korea
* Bangladesh
* Sri Lanka
* Indonesia
* Malaysia
* Philippines
* Thailand
* Vietnam
* Singapore
* Australia
* New Zealand

The reports analysis Neisseria Gonorrhoeae Infections Treatment market in Asia Pacific by products type:
* Type I
* Type II
* Type III

The reports analysis Neisseria Gonorrhoeae Infections Treatment market in Asia Pacific by application as well:
* Application I
* Application II
* Application III

Reasons to Purchase this Report:

* Analyzing the outlook of the market with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and non-economic aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Distribution Channel sales Analysis by Value
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Any special requirements about this report, please let us know and we can provide custom report.

レポート目次

Table of Contents

Chapter One Neisseria Gonorrhoeae Infections Treatment Overview
1.1 Neisseria Gonorrhoeae Infections Treatment Outline
1.2 Classification and Application
1.3 Manufacturing Technology

Chapter Two Industry Chain Analysis
2.1 Value Chain Analysis
2.2 Porter Five Forces Model Analysis
2.3 Cost Structure Analysis

Chapter Three Market Dynamics of Neisseria Gonorrhoeae Infections Treatment Industry
3.1 Latest News and Policy
3.2 Market Drivers
3.3 Market Challenges

Chapter Four Asia Pacific Market of Neisseria Gonorrhoeae Infections Treatment (2014-2019)
4.1 Neisseria Gonorrhoeae Infections Treatment Supply
4.2 Neisseria Gonorrhoeae Infections Treatment Market Size
4.3 Import and Export
4.4 Demand Analysis
4.5 Market Competition Analysis
4.6 Price Analysis
4.7 Country-wise Analysis

Chapter Five Asia Pacific Market Forecast (2019-2024)
5.1 Neisseria Gonorrhoeae Infections Treatment Supply
5.2 Neisseria Gonorrhoeae Infections Treatment Market Size
5.3 Import and Export
5.4 Demand Analysis
5.5 Market Competition Analysis
5.6 Price Analysis
5.7 Country-wise Analysis

Chapter Six Asia Pacific Raw Material Supply Analysis
6.1 Raw Material Supply
6.2 Raw Material Producers Analysis
6.3 Analysis of the Influence of Raw Material Price Fluctuation

Chapter Seven Asia Pacific Neisseria Gonorrhoeae Infections Treatment Consumer Analysis
7.1 Asia Pacific Major Consumers Information
7.2 Asia Pacific Major Consumer Demand Analysis

Chapter Eight Analysis of Asia Pacific Key Manufacturers (Including Company Profile, SWOT Analysis, Production Information etc.)
8.1 Allergan Plc
8.2 BioDiem Ltd
8.3 Biolytics Pharma
8.4 Debiopharm International SA
8.5 F. Hoffmann-La Roche Ltd.
……
……

Chapter Nine Research Conclusions of Asia Pacific Neisseria Gonorrhoeae Infections Treatment Industry

Tables and Figures

Figure Commercial Product of Neisseria Gonorrhoeae Infections Treatment
Table Classification of Neisseria Gonorrhoeae Infections Treatment
Table Application of Neisseria Gonorrhoeae Infections Treatment
Figure Porter Five Forces Model Analysis of Asia Pacific Neisseria Gonorrhoeae Infections Treatment
Figure Production Cost Analysis of Asia Pacific Neisseria Gonorrhoeae Infections Treatment
Table Neisseria Gonorrhoeae Infections Treatment Market Drivers & Market Challenges
Table 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Capacity List
Table 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Capacity Share List
Figure 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Capacity Share
Table 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Production List
Table 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Production Share List
Figure 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Production Share
Figure 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Capacity Production and Growth Rate
Table 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Production Value (Million USD) List
Figure 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Production Value and Growth Rate
Table 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Production Value Share List
Figure 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Production Value Share List
Table 2014-2019 Asia Pacific Supply and Consumption of Neisseria Gonorrhoeae Infections Treatment
Table 2014-2019 Asia Pacific Import and Export of Neisseria Gonorrhoeae Infections Treatment
Table 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Demand List by Application
Figure 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Demand by Application
Table 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Demand Share List by Application
Figure 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Demand Share by Application
Table 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Country-wise Consumption List
Figure 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Country-wise Consumption
Table 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Country-wise Consumption Share List
Figure 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Country-wise Consumption Share
Table 2014-2019 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Capacity Production Cost Profit and Gross Margin List
Table 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Capacity List
Table 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Capacity Share List
Figure 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Capacity Share
Table 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Production List
Table 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Production Share List
Figure 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Key Manufacturers Production Share
Figure 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Capacity Production and Growth Rate
Figure 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Production Value and Growth Rate
Table 2019-2024 Asia Pacific Supply and Consumption of Neisseria Gonorrhoeae Infections Treatment
Table 2019-2024 Asia Pacific Import and Export of Neisseria Gonorrhoeae Infections Treatment
Table 2019-2024 Asia Pacific Demand of Neisseria Gonorrhoeae Infections Treatment by Application
Figure 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Demand by Application
Table 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Demand Share List by Application
Figure 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Demand Share by Application
Table 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Country-wise Consumption List
Figure 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Country-wise Consumption
Table 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Country-wise Consumption Share List
Figure 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Country-wise Consumption Share
Table 2019-2024 Asia Pacific Neisseria Gonorrhoeae Infections Treatment Capacity Production Cost Profit and Gross Margin List
Table Asia Pacific Neisseria Gonorrhoeae Infections Treatment Raw Material Suppliers
Table Key End Users List
Table Profile of Allergan Plc
Table SWOT Analysis of Allergan Plc
Table Allergan Plc Neisseria Gonorrhoeae Infections Treatment Product Specification
Table 2014-2019 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Capacity Production and Growth Rate
Figure 2014-2019 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Production Global Market Share
Table SWOT Analysis of BioDiem Ltd
Figure BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Products
Table 2014-2019 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Product Capacity Production Price Cost Production Value List
Figure 2014-2019 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Capacity Production and Growth Rate
Figure 2014-2019 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Production Global Market Share
Table SWOT Analysis of Biolytics Pharma
Figure Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Product
Table Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Product Specification
Table 2014-2019 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Capacity Production and Growth Rate
Figure 2014-2019 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Production Global Market Share
Table Profile of Debiopharm International SA
Table SWOT Analysis of Debiopharm International SA
Figure Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Product
Table Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Product Specification
Table 2014-2019 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Capacity Production and Growth Rate
Figure 2014-2019 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Production Global Market Share
Table Profile of F. Hoffmann-La Roche Ltd.
Table SWOT Analysis of F. Hoffmann-La Roche Ltd.
Figure F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Product
Table 2014-2019 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Product Capacity Production Price Cost Production Value List
Figure 2014-2019 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Capacity Production and Growth Rate
Figure 2014-2019 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Production Global Market Share
……
……


以下、関連資料のご紹介
  • 分子クラミジアトラコマチス（CT）/ 淋菌（NG）診断機器のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Molecular Chlamydia Trachomatis Ct Neisseria Gonorrhoeae Ng Diagnostic Equipment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0635736 2019年12月 141Pages
    分子クラミジアトラコマチス（CT）/ 淋菌（NG）診断機器のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます...
  • 目の感染症治療のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Eye Infections Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0642329 2019年12月 141Pages
    目の感染症治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は目の感染症治療の市場概要、産業チェー...
  • 人工関節感染症治療のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Prosthetic Joint Infections Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0632013 2019年12月 138Pages
    人工関節感染症治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は人工関節感染症治療の市場概要、産...
  • エプスタインバーウイルス（HHV-4）感染症治療のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Epstein-Barr Virus (HHV-4) Infections Treatment Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0642627 2019年12月 137Pages
    エプスタインバーウイルス（HHV-4）感染症治療のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書はエ...
  • 類鼻疽菌感染症治療薬のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Burkholderia Pseudomallei Infections Drug Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0647592 2019年12月 139Pages
    類鼻疽菌感染症治療薬のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は類鼻疽菌感染症治療薬の市場概要...
  • ポックスウイルス科感染薬のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Poxviridae Infections Drug Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0632319 2019年12月 142Pages
    ポックスウイルス科感染薬のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書はポックスウイルス科感染薬の...
  • 病院治療グラム陰性感染のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Hospital Treated Gram Negative Infections Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0639567 2019年12月 147Pages
    病院治療グラム陰性感染のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は病院治療グラム陰性感染の市場...
  • ライノウイルス感染薬のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Rhinovirus Infections Drug Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0631222 2019年12月 144Pages
    ライノウイルス感染薬のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書はライノウイルス感染薬の市場概要...
  • インフルエンザAウイルス,H3N2サブタイプ感染薬のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Influenza A Virus, H3N2 Subtype Infections Drug Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0638676 2019年12月 144Pages
    インフルエンザAウイルス,H3N2サブタイプ感染薬のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は...
  • 院内感染(HAI) 制御のアジア市場：市場規模・シェア・価格・動向・予測
    Asia Pacific Hospital Acquired Infections Hais Control Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast
    D0FB0639586 2019年12月 135Pages
    院内感染(HAI) 制御のアジア太平洋市場規模は2014～2018年期間中に年平均XX%成長して2018年には$XX millionドルになっており、2019～2024年期間中には年平均XX%成長して2024年までには$XX millionまで成長すると予測されます。本書は院内感染(HAI) 制御の...